[First Quarter 2011 Results First Quarter 2011 Results Net revenue in the first quarter of 2011 was $13.0 million, compared to $18.9 million in the first quarter of 2010 and $24.4 million in the fourth quarter of 2010. (Figures from prior periods have been restated to account for discontinued operations following the divestiture of non-core IC businesses in December 2010.)]
[Form 6-K TABLE OF CONTENTS Page 3 4]
[This Form 6-K consists of: (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) NOTICE OF BOARD MEETING]
[This Form 6-K consists of: (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) NOTICE OF BOARD MEETING]
[China Biologics 2 Plasma Collection Stations in Guizhou Province Have Been Inspected and Relicensed, 4 Other Stations in Disallowed Counties Closed on August 1, 2011 TAIAN, China, August 1, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic, or the Company), a leading plasma-based biopharmaceutical company in China, today announced that 2 of its plasma collection stations, in] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 1, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]
[SouFun Declares Cash Dividends to Shareholders BEIJING, August 1, 2011 SouFun Holdings Limited (NYSE: SFUN, SouFun), the leading real estate and home furnishing Internet portal in China, today announced that its Board of Directors has approved and declared a cash dividend of US$1.00 per share on SouFuns ordinary shares. Each of the SouFuns American depositary shares (ADS) represents one]
[China Biologics 2 Plasma Collection Stations in Guizhou Province Have Been Inspected and Relicensed, 4 Other Stations in Disallowed Counties Closed on August 1, 2011 TAIAN, China, August 1, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic, or the Company), a leading plasma-based biopharmaceutical company in China, today announced that 2 of its plasma collection stations, in] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 1, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]
